Brief: TCAR Achieves Favorable Outcomes Versus Carotid Endarterectomy In Patients With Carotid Artery Disease
June 13 (Reuters) - Silk Road Medical Inc SILK.O :
* TCAR ACHIEVES FAVORABLE OUTCOMES VERSUS. CAROTID
ENDARTERECTOMY
IN PATIENTS WITH CAROTID ARTERY DISEASE
* SILK ROAD MEDICAL INC - RESULTS OF TCAR SURVEILLANCE
PROJECT ARE
OVERWHELMINGLY POSITIVE ON A LARGE DATASET OF PATIENTS
* SILK ROAD MEDICAL INC - SIGNIFICANT REDUCTION IN MORTALITY
AT 30
DAYS AND 1 YEAR IN TCAR PROJECT
* SILK ROAD MEDICAL INC - TCAR HAD STATISTICALLY EQUIVALENT
IN-HOSPITAL STROKE AND DEATH RATES AS CEA STUDY
Source text for Eikon: ID:nGNX8PWw21
Further company coverage: SILK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silk Road Medical
See all newsBrief: Silk Road Medical Boston Scientific To Be Required To Pay Co Termination Fee Of $69.5 Million If Merger Agreement Terminated Under Certain Circumstances
Boston Scientific to buy Silk Road Medical in $1.16 billion deal (updated)
Brief: Boston Scientific Announces Agreement to Acquire Silk Road Medical
Brief: Silk Road Medical Announces Definitive Agreement To Be Acquired By Boston Scientific
Boston Scientific to buy Silk Road Medical for $1.16 billion